FDA Says It’s The Law, Denies Petition Requesting GDUFA Fee Payment Changes
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency also says only Congress could enact fee waivers and exemptions, but Square Pharmaceuticals indicates it will join lobbying efforts to create them.